This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT4E0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,547.94, is for the delivery of 4,566,422,443 units of Tamsulosin HCL 0.4 mg capsules, with a completion date of November 14, 2024.
The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/12/25, 9:12 AM